The US Food and Drug Administration (FDA) recently issued its draft guidance, Considerations for the Use of Artificial Intelligence to ...

While barring CBDCs, the order leaves space for the establishment of privately-issued “stablecoins” and creates a ...

President Donald Trump signed an Executive Order revoking 78 executive orders issued by the Biden administration. Among these ...

The FedRAMP Emerging Technology Prioritization Framework, which was established last year to accelerate the use of systems ...

With private companies set to invest nearly $500 billion and the reversal of a previous presidential order, development of ...

Anjali Das and Gregory Parker of Wilson Elser explain that as cyber threats escalate in frequency and sophistication, it is ...

Enterprises need to invest as much in their data as they do in their AI technology to drive tangible, measurable results.

Discover new crypto releases causing a frenzy among investors. Stay ahead and learn about the latest opportunities in the crypto market.

New directive scraps Biden-era restrictions and accelerates AI innovation to bolster national security and economic growth.

Explore the key challenges of AI ethics in 2025, including accountability, transparency, and regulations in the EU, US, ...

PRNewswire/ -- e&, a global technology group, has collaborated with IBM (NYSE: IBM) to deploy a pioneering, end-to-end, multi-model Artificial Intelligence (AI) and Generative AI governance solution.

By integrating brain and body data through wearable technology, the platform provides biomarker feedback, and leverages advanced AI to deliver tailored health protocols.